Vivani Medical's Innovations Discussed at Major Investment Forum

Vivani Medical at the H.C. Wainwright Conference

ALAMEDA, Calif. — Vivani Medical, Inc. (NASDAQ: VANI) is excited to announce that CEO Adam Mendelsohn, Ph.D., will be presenting an overview of the company's innovative approaches to treatment at the H.C. Wainwright 27th Annual Global Investment Conference in New York City. This premier event is set to take place over several days with Dr. Mendelsohn's presentation scheduled for the morning of September 10.

Details about the Presentation

During his time at the conference, Dr. Mendelsohn will discuss the company's advancements in miniature drug delivery systems, specifically their revolutionary NanoPortal™ implant technology. This breakthrough aims to tackle the critical issue of medication non-adherence, which afflicts nearly half of patients globally. The conference presentation will cover how these long-acting implants can vastly improve outcomes for patients managing chronic conditions.

Event Overview

Date: September 10
Time: 1:00 PM - 1:30 PM, Eastern Time
Venue: Lotte New York Palace Hotel

Insights into NanoPortal™ Technology

Vivani's flagship product candidate, NPM-139, is an innovative semaglutide implant designed for chronic weight management in obese or overweight patients. Dr. Mendelsohn will elaborate on its anticipated launch in clinical development, slated to begin in the near future pending regulatory approvals.

Benefits of the Long-Acting Implants

The NanoPortal™ technology stands out due to its ability to deliver therapeutic agents steadily over extended durations. This is pivotal for enhancing patient adherence to treatment regimens, thereby improving their overall health outcomes. The innovative approach also circumvents common issues faced by patients using daily or weekly medications, such as tolerability concerns and reduced efficacy. With the potential for a once-yearly dosing regimen, Vivani is transforming how chronic conditions are managed.

Emerging Pipeline and Future Developments

In addition to NPM-139, Vivani is advancing other promising candidates including NPM-115, targeting chronic weight management, and NPM-119 for type-2 diabetes treatment. Each product utilizes the same proprietary technology, aiming to ensure improved adherence and better therapeutic outcomes for patients.

The Importance of Ongoing Research

Medication non-adherence is a significant challenge in healthcare, impacting approximately 50% of patients. By providing long-acting, implantable solutions, Vivani Medical seeks to ensure that patients can consistently benefit from their prescribed treatments. The company's research and development efforts are pivotal in contributing to the future of biopharmaceutical solutions.

Company Overview

Vivani Medical, based in California, employs its proprietary technologies to create biopharmaceutical implants aimed at sustained drug delivery. The company's innovative solutions target challenging medical issues, placing a strong emphasis on improving patient compliance through advanced drug administration methods. CEO Adam Mendelsohn's engagement at the H.C. Wainwright Conference highlights the ongoing commitment of Vivani to transform the landscape of chronic disease management.

Frequently Asked Questions

What will Dr. Mendelsohn present at the conference?

Dr. Mendelsohn will discuss Vivani's innovative drug implants and their benefits for chronic disease management.

What is the significance of the NanoPortal™ technology?

The NanoPortal™ technology allows for long-acting drug delivery, improving patient adherence and health outcomes.

What are Vivani's key product candidates?

Vivani's priority products include NPM-139 for weight management, NPM-115, and NPM-119 for diabetes.

When is the H.C. Wainwright Conference?

The conference is scheduled for September 8-10, with Dr. Mendelsohn's presentation on September 10.

How can I find out more about Vivani Medical?

For further information about the company and its products, you can visit their official website or contact their investor relations team.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.